Folx Owns LGBTQIA Clinician Network
Liana Guzmán, CEO of Folx, on the $400B market for LGBTQIA healthcare
Owning the clinician network means Folx is not just a lead generator for outside doctors, it is building the care experience itself. That matters because the product is not only a video visit, it is the intake flow, the clinical judgment, the follow up messages, the lab ordering, the prescription workflow, and the referral handoff, all designed for queer and trans patients who often have to explain themselves in traditional care settings.
-
This model is more operationally heavy than the contractor marketplace used by early telehealth companies like Ro and Hims. Those companies scaled quickly by connecting patients to external doctors, while Folx chose more control so it could standardize affirming care across primary care, gender care, sexual health, and later mental health.
-
The vertical integration shows up in the workflow. Members can book with a Folx clinician, get labs or imaging ordered, receive prescriptions through a partner pharmacy for some medications, use insurance for visits in many plans, and get referred into a vetted in person network when telehealth is not enough.
-
That tighter model also helps explain early fit. Folx said it reached thousands of patients with double digit growth in its first year, and later expanded into primary care, support groups, insurance acceptance, and a broader care team. The wedge was trust, then the company widened into a fuller healthcare relationship.
The next step is turning a specialized telehealth service into a durable medical home for LGBTQIA patients. As Folx adds more insurance coverage, more primary care use cases, and more in house care pathways, the company can capture more visits per member and become harder to replace than single condition telehealth apps.